IUX24
TopMarketWorldEconomyFinanceTechnologyBusinessPoliticsAnalysis & Opinion

Revolution Medicines Wins EU Panel Backing for Drug

European regulators recommended approval for Revolution Medicines pancreatic cancer drug Rasonque. The once-daily oral treatment targets aggressive tumors and moves toward final EU review.

Xurve View
Insights:
The exterior of EMA, European Medicines Agency is seen in Amsterdam, Netherlands December 18, 2020. Picture taken through glass. REUTERS/Piroschka van de Wouw

REVOLUTION MEDICINES INC received European Medicines Agency committee backing on Thursday morning for its pancreatic cancer treatment Rasonque. The endorsement brings the once-daily oral drug closer to a potential European launch for metastatic disease.
IUX24

IUX24 AI-powered financial news and market intelligence. Think and act like smart money.

IFZA Properties, Dubai Silicon Oasis, DSO-IFZA, Dubai, United Arab Emirates

Copyright IUX24 MEDIA - FZCO. All rights reserved.

Powered by AI • Made with precision

IUX24 is an information and analytics platform providing news, market data, analytical tools, and AI-powered features for informational and educational purposes. The Services and information provided do not constitute investment advice, trading signals, or brokerage services. Investing involves risk, and Users should carefully evaluate information before making investment decisions.